SynthesisWorld journal of urology2019

Alpha-blockers with or without phosphodiesterase type 5 inhibitor for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review and meta-analysis.

Jianzhong Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.